Tag

Health X Platform Limited

6 articles
Health X Platform Limited is demonstrating revenue growth while navigating significant losses, signaling a period of strategic investment and operational challenges. The company reported a 34% year-over-year revenue increase to ₹378.1 Cr in Q4 FY26, alongside a consolidated net loss of ₹1,297 Cr for the fiscal year, partially attributed to exceptional items like labor code impacts and a substantial share buyback. Promoter Banwari Lal Mittal has been steadily increasing his stake through market purchases, indicating confidence in the company's five-year growth plan, which includes geographic expansion and AI integration. Investors should monitor the company’s ability to translate revenue growth into profitability as it executes its strategic initiatives.
Health X Platform Q4 FY26 Earnings Call Transcript
Health X Platform Ltd reported Q4 revenue growth of 22% YoY to ₹356 crore and reduced EBITDA losses by 29% YoY to ₹20 crore. The company announced a corporate restructuring demerging its finance divis
Health X Platform Q4 FY26 Conference Call Recording
Health X Platform submitted audio recording of its Q4 FY26 investor conference call to stock exchanges. The call, held on 12th June 2026, featured senior management discussing quarterly and annual per
Health X Platform Promoter Ravi Kant Sharma Sells 2.5 Lakh Shares
Health X Platform Ltd discloses a promoter share sale under SEBI PIT Regulations via Form C filing. Promoter Ravi Kant Sharma sold 250,000 equity shares worth ₹7.50 crore via market sale on June 3, 20
Promoter Banwari Lal Mittal Buys 5,000 Shares
Health X Platform Ltd (formerly Sastasundar Ventures Ltd) disclosed promoter acquisition under SEBI Insider Trading Regulations 2015. Promoter Banwari Lal Mittal acquired 5,000 equity shares via marke
Promoter Mittal Buys 5,000 Shares in Health X Platform
Health X Platform Limited filed a SEBI Regulation 7(2) insider trading continual disclosure on 27 March 2026. Promoter Banwari Lal Mittal acquired 5,000 equity shares via market purchase on 24 March 2
Banwari Lal Mittal Acquires 5,132 Shares via Market
Health X Platform Ltd filed a SEBI Regulation 7(2) insider trading continual disclosure for promoter Banwari Lal Mittal's share acquisition. Mittal purchased 5,132 equity shares via market purchase on